SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CCXI

Churchill Capital Corp XI (NASDAQ:CCXI)

US · Delayed Price · Currency is USD
Financial Services · Shell Companies
11.26+0.57 (+5.33%)
 
Market cap
$472M
Insider Score
Health Score
Listed since
Feb 9, 2026
Market Cap471.79M+9.8%
Revenue (ttm)0
Net Income-134.20M
EPS-2.41
Shares Out41.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,782,294
Open11.03
Previous Close10.69
Day's Range10.81 - 12.17
52-Week Range8.00 - 19.69
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a
Insider Score
––Not scored
CCXI Insider Score

Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About CCXI

Churchill Capital Corp. XI operates as a Special Purpose Acquisition Company (SPAC), an entity created without existing operations or assets. Its sole mission is to execute a strategic business combination, such as a merger, share exchange, asset purchase, or corporate reorganization, with one or more established companies. Michael Stuart Klein founded this firm on June 4, 2025, and its principal offices are located in New York City.

Address
640 Fifth Avenue, 12th Floor, New York, NY, 10019, US
Market Cap
472 million
Employees
2
Industrial Classification
Shell Companies
Financial Health Score
Sound
From CCXI’s reported statements · FY2025 · 4 of 5 pillars

Ask Barron about CCXI

1 Day
+5.33%
5 Days
+19.91%
1 Month
-6.71%
6 Months
+10.18%
1 Year
+9.75%

$CCXI stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of CCXI by members of U.S. Congress

PoliticianTypeTraded
Josh GottheimerHouse / DSale$1.00K – $15.00KOct 20, 2022
Josh GottheimerHouse / DPurchase$1.00K – $15.00KApr 19, 2022
Josh GottheimerHouse / DSale$1.00K – $15.00KMar 15, 2022
Josh GottheimerHouse / DPurchase$1.00K – $15.00KDec 2, 2021

Recently reported changes in CCXI holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CCXI's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CCXI Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CCXI Revenue by Segment

$422.13MTotal
SegmentRevenue% of All
Marketable securities and cash held in Trust Account$420.88M99.70%
Cash$1.25M0.30%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CCXI patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CCXI from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CCXI

ETFEst. Holding Size
HUMNRoundhill Investments - Roundhill Humanoid Robotics ETF$5.54M
STSBiShares Factors US Small Blend Style ETF$5.54K
FOMOAXS FOMO ETF$0

Estimated from each fund’s disclosed top holdings × AUM

CCXI Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for CCXI yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from CCXI’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
No data yet
—
News & Sentiment
100% of score
72

News check: Shareholder approval and capital raise confirmed; concrete commercial progress with customer deployments, NVIDIA partnership expansion, and manufacturing pilots demonstrate execution momentum.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.